# The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, Paragraph 4: Amendment of the Prescription Only Medicines (Human Use) Order 1997

Extent: E+W+S+N.I.

After article 5(1) of the Prescription Only Medicines (Human Use) Order 1997 (exempt medicinal products) , insert—
“(1A) In paragraph (1) “marketing authorisation” means—
(a) in relation to medicinal products for sale or supply in Great Britain, a UKMA(GB) or UKMA(UK);
(b) in relation to medicinal products for sale or supply in Northern Ireland, a UKMA(NI) or UKMA(UK), an EU marketing authorisation or a parallel import licence.”

---
Source: https://www.legislation.gov.uk/uksi/2019/775/schedule/8/paragraph/4 (the official version)
Page: https://openlegislation.uk/human-medicines-amendment-etc-eu-exit-regulations-2019/schedule-8/paragraph-4
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.